Dec 02, 2016 12:30 pm UTC| Business
NEW YORK, Dec. 02, 2016 -- Stemline Therapeutics, Inc. (Nasdaq:STML) announced today that SL-401, a novel targeted therapeutic directed to CD123, will be featured in seven presentations, including three oral...
Aehr Test Systems to Participate in the Fifth Annual Midtown CAP Investor Summit in New York
Dec 02, 2016 12:30 pm UTC| Business
FREMONT, Calif., Dec. 02, 2016 -- Aehr Test Systems (NASDAQ:AEHR), a worldwide supplier of semiconductor test and burn-in equipment, today announced that Gayn Erickson, President and CEO, will participate in the Fifth...
Monro Muffler Brake, Inc. Declares Quarterly Cash Dividend
Dec 02, 2016 12:30 pm UTC| Business
ROCHESTER, N.Y., Dec. 02, 2016 -- Monro Muffler Brake, Inc. (Nasdaq:MNRO), a leading provider of automotive undercar repair and tire services, today announced that its Board of Directors has declared a quarterly cash...
Dec 02, 2016 12:21 pm UTC| Business
NEW YORK, Dec. 02, 2016 -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) (Tonix), which is developing a next-generation treatment for posttraumatic stress disorder (PTSD), announced today that it will present...
uniQure to Present at the Genetic Rx Boston Biotech Conference at Harvard Medical School
Dec 02, 2016 12:04 pm UTC| Business
Amsterdam, The Netherlands, Dec. 02, 2016 -- Lexington, MA and Amsterdam, the Netherlands, December 2, 2016 - uniQure N.V. (NASDAQ: QURE), a leader in human gene therapy, today announced its participation in two panel...
Dec 02, 2016 12:01 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Dec. 02, 2016 -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical stage biotechnology company focused on the discovering and developing novel small molecule drugs directed against tumor...
NeuroDerm Announces Top-Line Results of Pilot PK Trial Comparing ND0701 with Commercial Apomorphine
Dec 02, 2016 12:00 pm UTC| Business
REHOVOT, Israel, Dec. 02, 2016 -- NeuroDerm Ltd. (Nasdaq:NDRM), a clinical stage pharmaceutical Company developing drugs for central nervous system (CNS) disorders, today announced the completion of a pilot study (trial...